The Nephrotoxicity of Vancomycin. Issue 3 (5th June 2017)

• Record Type: Journal Article
• Authors: Filippone, EJ; Kraft, WK; Farber, JL
• Is Part Of: Clinical pharmacology & therapeutics. Volume 102:Issue 3(2017)
• Page Start: 459
• Page End: 469
• Publication Date: 2017-06-05
• Subjects: Pharmacology -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1002/cpt.726
• Languages: English
• ISSNs: 0009-9236

Abstract

Abstract : Vancomycin use is often associated with nephrotoxicity. It remains uncertain, however, to what extent vancomycin is directly responsible, as numerous potential risk factors for acute kidney injury frequently coexist. Herein, we critically examine available data in adult patients pertinent to this question. We review the pharmacokinetics/pharmacodynamics of vancomycin metabolism. Efficacy and safety data are discussed. The pathophysiology of vancomycin nephrotoxicity is considered. Risk factors for nephrotoxicity are enumerated, including the potential synergistic nephrotoxicity of vancomycin and piperacillin‐tazobactam. Suggestions for clinical practice and future research are given.